Constructive Bio
Cambridge
About Constructive Bio
At Constructive Bio we rewrite the genome to build the biomolecules of the future. Our unique technology turns living cells into biofactories, creating sustainable new materials and therapeutics. With full control of the genetic sequence and code, we are exploring chemical space previously unreached by natural biology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $74.2M
- Last round: Series Unknown (Apr 2025)
- Website: constructive.bio
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/constructive-bio-62438 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.